Home » Topics » BioWorld Science

BioWorld Science
RSS

New polycyclic antitumor agents prepared and tested at Banyu

June 4, 2004

Japan Energy describes novel microtubule polymerization inhibitors

June 4, 2004

New GLP-2 analogues for intestinal disorders designed at Novo Nordisk

June 4, 2004

Tanabe Seiyaku claims RANKL antagonists with utility in osteoporosis

June 4, 2004

New antihistaminic agents under study at Japan Energy

June 4, 2004

Sumitomo presents new antifungal agents from Streptomyces sp.

June 4, 2004

Antifibrotic effects of EM-703 studied in mice

June 4, 2004

ONO-EI-600 may offer protection against ventilator-induced lung injury

June 4, 2004

Activity of CAT-213 investigated in vitro and in vivo

June 4, 2004

Nutropin Depot to be discontinued

June 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...